Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.
2.

Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis.

Dascher CC, Hiromatsu K, Xiong X, Morehouse C, Watts G, Liu G, McMurray DN, LeClair KP, Porcelli SA, Brenner MB.

Int Immunol. 2003 Aug;15(8):915-25.

3.

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST.

Nat Med. 2003 May;9(5):533-9. Epub 2003 Apr 14.

PMID:
12692540
4.
5.

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Taylor JL, Turner OC, Basaraba RJ, Belisle JT, Huygen K, Orme IM.

Infect Immun. 2003 Apr;71(4):2192-8.

6.

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, Collins FM, Morris SL, Jacobs WR Jr.

Nat Med. 2002 Oct;8(10):1171-4. Epub 2002 Sep 9.

PMID:
12219086
7.

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.

Moreira AL, Tsenova L, Aman MH, Bekker LG, Freeman S, Mangaliso B, Schröder U, Jagirdar J, Rom WN, Tovey MG, Freedman VH, Kaplan G.

Infect Immun. 2002 Apr;70(4):2100-7.

8.

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P.

Infect Immun. 2002 Feb;70(2):672-8.

9.

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.

Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR Jr, Bloom BR.

Infect Immun. 2000 May;68(5):2888-98.

10.

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Turner J, Rhoades ER, Keen M, Belisle JT, Frank AA, Orme IM.

Infect Immun. 2000 Mar;68(3):1706-9.

11.

ESAT-6 subunit vaccination against Mycobacterium tuberculosis.

Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P.

Infect Immun. 2000 Feb;68(2):791-5.

12.
14.

Comparative genomics of BCG vaccines by whole-genome DNA microarray.

Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM.

Science. 1999 May 28;284(5419):1520-3.

15.

Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.

Baldwin SL, D'Souza C, Roberts AD, Kelly BP, Frank AA, Lui MA, Ulmer JB, Huygen K, McMurray DM, Orme IM.

Infect Immun. 1998 Jun;66(6):2951-9.

16.

Has BCG attenuated to impotence?

Behr MA, Small PM.

Nature. 1997 Sep 11;389(6647):133-4. No abstract available.

PMID:
9296487
17.

Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection.

Hernandez-Pando R, Pavön L, Arriaga K, Orozco H, Madrid-Marina V, Rook G.

Infect Immun. 1997 Aug;65(8):3317-27.

18.

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Talbot EA, Perkins MD, Silva SF, Frothingham R.

Clin Infect Dis. 1997 Jun;24(6):1139-46. Review.

19.

Auxotrophic vaccines for tuberculosis.

Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs WR Jr, Bloom BR.

Nat Med. 1996 Mar;2(3):334-7.

PMID:
8612234
20.
Items per page

Supplemental Content

Write to the Help Desk